BC057022 Activators
Fam222a, a member of the family with sequence similarity 222, emerges as a gene expressed predominantly in the inner ear, sharing orthology with human FAM222A. Although direct activators of Fam222a might not be readily identified, various chemicals indirectly influence its activity through modulation of specific signaling pathways. The activation mechanisms of Fam222a involve responses to chemicals that target key cellular signaling pathways. For instance, kinase inhibitors like Staurosporine, SB203580, and U0126 indirectly activate Fam222a by influencing various kinase-mediated pathways. Inhibition of p38 MAPK by SB203580 and MAPK by U0126 reveals the intricate connection between these pathways and Fam222a expression and function. Additionally, inhibitors targeting PI3-kinase, such as Wortmannin and LY294002, indirectly activate Fam222a by disrupting PI3-kinase signaling, indicating the involvement of PI3-kinase in Fam222a regulation.
Moreover, Fam222a responds to inhibitors targeting JNK, MEK1, Src family kinases, mTOR, PKC, EGFR, and JAK2, highlighting its sensitivity to diverse signaling cascades. These inhibitors indirectly activate Fam222a by influencing downstream pathways associated with cellular processes in the inner ear. In summary, Fam222a is a gene with specific expression in the inner ear, suggesting a role in auditory and vestibular functions. The indirect activation mechanisms involve modulation of various signaling pathways crucial for cellular processes, indicating the gene's importance in inner ear homeostasis and function. Understanding the activation mechanisms of Fam222a contributes to our knowledge of the intricate regulatory networks governing inner ear biology and provides insights into potential avenues for further research in auditory and vestibular physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a broad-spectrum kinase inhibitor, indirectly activates Fam222a by inhibiting multiple kinases. Modulating kinase activities influences signaling pathways, impacting Fam222a expression and function. Staurosporine’s role in kinase inhibition establishes an indirect activation mechanism for Fam222a through its impact on signaling cascades and associated cellular processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, indirectly activates Fam222a by dampening p38 MAPK signaling. Inhibition of p38 MAPK influences downstream pathways, affecting Fam222a expression and function. SB203580’s role in p38 MAPK inhibition establishes an indirect activation mechanism for Fam222a through its impact on signaling cascades and associated cellular processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, indirectly activates Fam222a by suppressing the JNK signaling pathway. Inhibition of JNK influences downstream pathways, affecting Fam222a expression and function. SP600125’s role in JNK pathway inhibition establishes an indirect activation mechanism for Fam222a through its impact on signaling cascades and associated cellular processes. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2, a Src family kinase inhibitor, indirectly activates Fam222a by inhibiting Src family kinases. Modulating Src family kinase activities influences signaling pathways, impacting Fam222a expression and function. PP2’s role in kinase inhibition establishes an indirect activation mechanism for Fam222a through its impact on signaling cascades and associated cellular processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, indirectly activates Fam222a by disrupting mTOR signaling. Inhibition of mTOR influences downstream pathways, affecting Fam222a expression and function. Rapamycin’s role in mTOR inhibition establishes an indirect activation mechanism for Fam222a through its impact on signaling cascades and associated cellular processes. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I, a PKC inhibitor, indirectly activates Fam222a by inhibiting protein kinase C (PKC). Modulating PKC activities influences signaling pathways, impacting Fam222a expression and function. Bisindolylmaleimide I’s role in PKC inhibition establishes an indirect activation mechanism for Fam222a through its impact on signaling cascades and associated cellular processes. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $96.00 $421.00 | 16 | |
AG1478, an EGFR inhibitor, indirectly activates Fam222a by suppressing EGFR signaling. Inhibition of EGFR influences downstream pathways, affecting Fam222a expression and function. AG1478’s role in EGFR inhibition establishes an indirect activation mechanism for Fam222a through its impact on signaling cascades and associated cellular processes. | ||||||
VX 745 | 209410-46-8 | sc-361401 sc-361401A | 10 mg 50 mg | $183.00 $842.00 | 4 | |
VX-745, a JAK2 inhibitor, indirectly activates Fam222a by suppressing the JAK2/STAT3 signaling pathway. Inhibition of JAK2 influences downstream pathways, affecting Fam222a expression and function. VX-745’s role in JAK2 inhibition establishes an indirect activation mechanism for Fam222a through its impact on signaling cascades and associated cellular processes. | ||||||